<--- Back to Details
First PageDocument Content
Cyclopropanes / Medicine / Carbamates / Organofluorides / Non-nucleoside reverse transcriptase inhibitors / Antiretroviral drug / Efavirenz / Viral load / Reverse-transcriptase inhibitor / HIV/AIDS / Chemistry / Organic chemistry
Date: 1999-10-29 04:20:02
Cyclopropanes
Medicine
Carbamates
Organofluorides
Non-nucleoside reverse transcriptase inhibitors
Antiretroviral drug
Efavirenz
Viral load
Reverse-transcriptase inhibitor
HIV/AIDS
Chemistry
Organic chemistry

) . ., RCG Analysis – CNAA2007 Resistance

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 1,17 MB

Share Document on Facebook

Similar Documents

RESTORATION OF PYRETHROID SUSCEPTIBILITY AFTER INDOOR RESIDUAL SPRAYING WITH CARBAMATES IN SENEGAL

DocID: 1ukdE - View Document

Anthelmintics / Benzimidazoles / Carbamates / Fenbendazole / Thioethers / Deworming / Worming / Schering-Plough / Dairy cattle / Drench / Chemistry

Put your dewormer where the worms are. Now is the time, to deworm with Safe-Guard ®. Strategic Deworming

DocID: 1rmBI - View Document

Anthelmintics / Chemistry / Benzimidazoles / Medicine / Carbamates / Clinical medicine / Veterinary drugs / RTT / Doramectin / Triclabendazole / Lungworm / Praziquantel

Clear Sustainable Control of Parasites in Sheep Group 3 Product

DocID: 1rcGD - View Document

Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

DocID: 1qWZQ - View Document

Ion channels / Electrophysiology / Biology / Integral membrane proteins / Physiology / Neuroscience / Carbamates / Retigabine / Potassium channel / Voltage-gated potassium channel

Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane

DocID: 1qUxQ - View Document